FDA approves CryoLife's heart patch

08/12/2009 | Forbes

The FDA granted approval to CryoLife for its CryoPatch SG, a human cardiac patch designed to repair or reconstruct the heart's right ventricular outflow tract, a surgery often done for pediatric patients with congenital heart defects. The company plans to start shipping the product late in the third quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN